DongKoo Bio & Pharma Completes 3 Billion Won Share Buyback

PUBT · 3d ago
DongKoo Bio & Pharma Completes 3 Billion Won Share Buyback
  • DongKoo Bio & Pharma completed repurchases of 822,134 shares, representing 2.89% of outstanding stock, under a KRW 3 billion trust contract.
  • The trust contract will terminate early on Oct. 28, 2026, following completion of the buyback.
  • The repurchased shares are slated for cancellation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DongKoo Bio & Pharma Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261028000134), on October 28, 2026, and is solely responsible for the information contained therein.